Talphera, Inc. (NASDAQ:TLPH) Short Interest Down 16.9% in June

Talphera, Inc. (NASDAQ:TLPH) saw a large decrease in short interest in June. As of June 15th, there was short interest totalling 139,800 shares, a decrease of 16.9% from the May 31st total of 168,300 shares. Approximately 0.8% of the company’s stock are short sold. Based on an average daily volume of 69,900 shares, the short-interest ratio is currently 2.0 days.

Talphera Trading Down 2.2 %

Shares of TLPH stock traded down $0.02 on Friday, hitting $0.89. 41,683 shares of the stock traded hands, compared to its average volume of 61,926. Talphera has a 1-year low of $0.43 and a 1-year high of $1.61. The stock’s fifty day moving average is $1.00.

Talphera (NASDAQ:TLPH) last posted its quarterly earnings results on Tuesday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.12. On average, research analysts forecast that Talphera will post -0.84 EPS for the current fiscal year.

Analysts Set New Price Targets

TLPH has been the topic of a number of recent analyst reports. Maxim Group initiated coverage on Talphera in a research report on Monday, May 6th. They issued a “buy” rating and a $3.00 target price on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Talphera in a research report on Wednesday, May 15th.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.